MENU
+Compare
NAOV
Stock ticker: NASDAQ
AS OF
Jul 10, 04:59 PM (EDT)
Price
$0.95
Change
-$0.00 (-0.00%)
Capitalization
1.8M

NAOV NanoVibronix Inc Forecast, Technical & Fundamental Analysis

NanoVibronix Inc manufactures noninvasive biological response-activating devices that target biofilm prevention, pain therapy, and wound healing and can be administered at home, without the assistance of medical professionals... Show more

NAOV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for NAOV with price predictions
Jul 09, 2025

NAOV's RSI Indicator recovers from oversold territory

The RSI Indicator for NAOV moved out of oversold territory on June 11, 2025. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 38 similar instances when the indicator left oversold territory. In of the 38 cases the stock moved higher. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 4 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

The Momentum Indicator moved above the 0 level on July 08, 2025. You may want to consider a long position or call options on NAOV as a result. In of 93 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for NAOV just turned positive on June 04, 2025. Looking at past instances where NAOV's MACD turned positive, the stock continued to rise in of 44 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where NAOV advanced for three days, in of 203 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

Following a 3-day decline, the stock is projected to fall further. Considering past instances where NAOV declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for NAOV entered a downward trend on June 06, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.384) is normal, around the industry mean (24.348). P/E Ratio (0.000) is within average values for comparable stocks, (77.706). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (5.667). Dividend Yield (0.000) settles around the average of (0.018) among similar stocks. P/S Ratio (1.428) is also within normal values, averaging (42.660).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. NAOV’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. NAOV’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 90, placing this stock worse than average.

View a ticker or compare two or three
NAOV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

a manufacturer of noninvasive biological response-activating devices

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
525 Executive Boulevard
Phone
+1 914 233-3004
Employees
14
Web
https://www.nanovibronix.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SCOR5.310.29
+5.78%
comScore
BIOA4.630.24
+5.47%
BioAge Labs Inc.
DK24.330.34
+1.42%
Delek US Holdings
KD42.85-0.53
-1.22%
Kyndryl Holdings
ARIS23.53-0.78
-3.21%
Aris Water Solutions

NAOV and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, NAOV has been loosely correlated with CLPT. These tickers have moved in lockstep 33% of the time. This A.I.-generated data suggests there is some statistical probability that if NAOV jumps, then CLPT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NAOV
1D Price
Change %
NAOV100%
-1.04%
CLPT - NAOV
33%
Loosely correlated
+4.12%
CDNA - NAOV
31%
Poorly correlated
+5.35%
SENS - NAOV
31%
Poorly correlated
-0.44%
RSMDF - NAOV
30%
Poorly correlated
N/A
EXAS - NAOV
29%
Poorly correlated
+3.31%
More